cephalosporin c has been researched along with adenosine monophosphate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Humes, HD; Weinberg, JM | 1 |
Hussar, DA | 1 |
Cusumano, JA; Daffinee, KE; Desbonnet, C; GarcĂa-Solache, M; LaPlante, KL; Piehl, EC; Rice, LB | 1 |
1 review(s) available for cephalosporin c and adenosine monophosphate
Article | Year |
---|---|
Alterations of renal tubular cell metabolism in acute renal failure.
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aminoglycosides; Animals; Anti-Bacterial Agents; Calcium; Cell Membrane; Cephalosporins; Gentamicins; Humans; Kidney Tubules; Lysosomes; Mercuric Chloride; Mercury; Mitochondria; Phospholipids | 1983 |
2 other study(ies) available for cephalosporin c and adenosine monophosphate
Article | Year |
---|---|
New Drugs 2021, Part 2.
Topics: Adenosine Monophosphate; Alanine; Amisulpride; Carbamates; Cefiderocol; Cephalosporins; Chlorophenols; COVID-19 Drug Treatment; Drug Approval; Drug Combinations; Fumarates; Humans; Indans; Organophosphates; Oxadiazoles; Piperazines; Spiro Compounds; Tetrazoles; Thiophenes; Tromethamine; United States; United States Food and Drug Administration | 2021 |
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an
Topics: Adenosine Monophosphate; Ampicillin; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Drug Synergism; Enterococcus faecalis; Ertapenem; Humans; Meropenem; Microbial Sensitivity Tests | 2022 |